Aqua Bounty Technologies, Inc. has signed an agreement with Stirling Products North America
Inc. for an exclusive option to distribute ProVale™ in the Chilean salmon market.
The strategic partnership will allow Aqua Bounty to target the Chilean salmon
market, which is the second largest in the world behind Norway.
Under the terms of the agreement, Aqua Bounty will
manage field trials required for proof of efficacy and market approval of the
product. The Company will test ProVale™ as a replacement for antibiotics in the
diets of farmed salmon. Subject to regulatory approval, the trials are expected
to begin shortly and last for a period of two to three months.
is an environmentally friendly and highly bioactive form of the currently
marketed beta glucan product for immune stimulation and disease management in
fish. Related websites:
Technologies Stirling Products North America To receive more animal feed news, subscribe
(Source: www.fishfarmer-magazine.com )
To comment, login here
Or register to be able to comment.